To determine the clinical significance of TAMs in CRC, we firstly examined the expression of TAMs markers (CD68, CD163) and EMT markers (E-cadherin, Vimentin) in serial sections from 81 CRC cases. This evidence concerns the gene CD68 and colorectal carcinoma.